81 related articles for article (PubMed ID: 18196636)
41. N-terminal probrain natriuretic peptide levels as a predictor of functional outcomes in patients with ischemic stroke.
Chang L; Yan H; Li H; Song Z; Gui Y; Yan Z; Li T; Duan D
Neuroreport; 2014 Sep; 25(13):985-90. PubMed ID: 25102374
[TBL] [Abstract][Full Text] [Related]
42. [Carotid artery disease in patients with ischemic stroke. Results of year-long observation conducted within the framework of prospective epidemiological studies, Warsaw, 1991-1992].
Ryglewicz D; Rozenfeld A; Barańska-Gieruszczak M; Czyrny M; Lechowicz W
Neurol Neurochir Pol; 1998; 32(2):255-64. PubMed ID: 9760545
[TBL] [Abstract][Full Text] [Related]
43. [Cryoglobulinemia and extracorporal plasma therapy in severe ischemic stroke].
Skvortsova VI; Konstantinova NA; Zelenkina LI; Komarov AN; Eremin II; Shamalov NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 10):47-51. PubMed ID: 15565838
[TBL] [Abstract][Full Text] [Related]
44. Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke.
Lagowska-Lenard M; Stelmasiak Z; Bartosik-Psujek H
Pharmacol Rep; 2010; 62(4):751-6. PubMed ID: 20885017
[TBL] [Abstract][Full Text] [Related]
45. [Neuromidin in the restoration of motor functions after ischemic stroke].
Maksimova MIu; Mikhal'chenko VN; Sineeva NA; Glebova OV; Vodop'ianov NP
Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(2):25-7. PubMed ID: 23528578
[TBL] [Abstract][Full Text] [Related]
46. [Changes in the hemostasis system and free-radical lipid oxidation in the acute stage of ischemic stroke in patients on neuroprotection treatment].
Izhbul'dina GI
Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 2):31-7. PubMed ID: 22677767
[TBL] [Abstract][Full Text] [Related]
47. [Efficacy of cereton in the acute period of ischemic stroke].
Ismagilov MF; Vasilevskaia OV; Gaĭfutdinov RT; Strakhova TM; Kuz'mina IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):35-6. PubMed ID: 19365389
[TBL] [Abstract][Full Text] [Related]
48. [Blood cell aggregation and oxidative stress in pathogenesis of ischemic stroke].
Fedorova TF; Aleksandrov MV; Sokolovskiĭ VV; Papaian LP; Mashkova NP
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 10):39-46. PubMed ID: 15565837
[TBL] [Abstract][Full Text] [Related]
49. [The dynamics of lipid peroxidation in patients with acute disorders of the cerebral circulation of an ischemic nature].
Suslina ZA; Fedorova TN; Kistenev BA; Khrapova EV; Maksimova MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(7):33-6. PubMed ID: 10441849
[TBL] [Abstract][Full Text] [Related]
50. [Crioglobulinemia in cerebral and coronal atherothrombosis].
Skvortsova VI; Konstantinova EV; Komarov AN; Eremin II; Shostak NA; Konstantinova NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; Suppl 15():51-6. PubMed ID: 16447554
[TBL] [Abstract][Full Text] [Related]
51. [An influence of submaximal (submineximal) doses of mexidol on oxidant stress and inflammation in the acute period of ischemic stroke].
Godunova AR; Rakhimova AA; Leontyeva OI; Talipova IG; Yakhin RM; Musin SG
Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(2):27-30. PubMed ID: 29560937
[TBL] [Abstract][Full Text] [Related]
52. Clinical analysis on alteration of thyroid hormones in the serum of patients with acute ischemic stroke.
Zhang Y; Meyer MA
Stroke Res Treat; 2010 Aug; 2010():. PubMed ID: 20847898
[TBL] [Abstract][Full Text] [Related]
53. [Total antioxidant status of blood in various types of ischemic stroke].
Kravtsov YI; Kravtsova EY; Selezneva SI; Sosnin DY
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8. Vyp. 2):37-42. PubMed ID: 28980580
[TBL] [Abstract][Full Text] [Related]
54. [Natural neurotrophic IgG autoantibodies in the blood serum of patients with different clinical outcomes after ischemic stroke].
Alferova VV; Gekht AB; Poletaev AB; Abrosimova AA; Belikova LP; Chumakova AA; Nikolaeva TIa; Gusev EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(1):56-60. PubMed ID: 18427521
[TBL] [Abstract][Full Text] [Related]
55. Thyroid hormones and functional outcomes after ischemic stroke.
O'Keefe LM; Conway SE; Czap A; Malchoff CD; Benashski S; Fortunato G; Staff I; McCullough LD
Thyroid Res; 2015; 8():9. PubMed ID: 26157487
[TBL] [Abstract][Full Text] [Related]
56. [Clinical and laboratory predictors of outcome in acute period of atherothrombotic ischemic stroke].
Shkrobot SI; Sokhor NR; Milevska-Vovchuk LS
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(3. Vyp. 2):26-30. PubMed ID: 28665366
[TBL] [Abstract][Full Text] [Related]
57. [Clinical and pharmacoeconomic peculiarities of the treatment with cerebrolysin in the period of rehabilitation of is ischemic stroke.].
Gusev EI; Gekht AB; Belousov IuB; Pavlov NA; Galanov DV; Popov GR; Mil'chakova LE
Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(10):26-33. PubMed ID: 18477976
[TBL] [Abstract][Full Text] [Related]
58. [Possibilities of the treatment of speech impairment in the acute stage of ischemic stroke using neuroprotective therapy].
Belskaya GN; Krilova LG; Sokolov MA; Izmailov IA
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(9 Pt 2):60-63. PubMed ID: 26525938
[TBL] [Abstract][Full Text] [Related]
59. [Use of sodium succinate in complex treatment of ischemic stroke].
Berdichevskiĭ MIa; Karmirian SA; Aristova LA; Geĭkov II; Miroshnichenko VE; Miasnikova LL; Badovskaia LA; Latashko VM; Ponomarenko RI
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; (Suppl 10):57-60. PubMed ID: 15565840
[TBL] [Abstract][Full Text] [Related]
60. [The active neuroprotective therapy of acute carotid ischemic stroke of moderate severity].
Kukhtevich II; Aleshina NI; Levashova OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(12 Pt 2):38-42. PubMed ID: 25726801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
